ChemoTech: Into Africa (Västra Hamnen)
Västra Hamnen Corporate Finance has released a research update on Scandiavian ChemoTech following its report for Q3 2018. We see exciting new opportunities following the company's entry into Africa and intention to explore the veterinary market. In the short term, we adjust our fair value range slightly to 17.00 – 25.70 SEK/share.· First order and distributor agreement in Africa · Exploring opportunities to enter veterinary market · We adjust our fair value range slightly lower In Scandinavian ChemoTech’s report for Q4 and full year 2018, which was published yesterday, the company